Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma

2.

Can Prior Authorization Be Better With Artificial Intelligence?

3.

De-Intensified Therapy Misses Mark in HPV-Positive Oropharyngeal Cancer

4.

Small Renal Mass Surveillance Does Not Affect Nephron-Sparing Surgery.

5.

Having a tattoo could increase your risk of developing lymphoma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot